Search results for "5-HT"

showing 10 items of 134 documents

Cisplatin increases the release of 5-hydroxytryptamine (5-HT) from the isolated vascularly perfused small intestine of the guinea-pig: Involvement of…

1991

Isolated segments of the guinea-pig small intestine were vascularly perfused and the release of 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) into the portal venous effluent determined by high pressure liquid chromatography with electrochemical detection. Release of acetylcholine from isolated superfused intestinal segments was determined as outflow of [3H]radioactivity from preparations preincubated with [3H]choline. Cisplatin (3 microM) increased the outflow of 5-HT and 5-HIAA by about 90%. At 30 and 100 microM cisplatin decreased the outflow of 5-HT and its metabolite by 40%-50%. The stimulatory effect of cisplatin was consistently observed only when the bicarbonate-…

MaleSerotoninmedicine.medical_specialtymedicine.drug_classMetaboliteGuinea PigsTetrodotoxinIn Vitro Techniqueschemistry.chemical_compoundInternal medicineIntestine SmallEnterochromaffin CellsmedicineAnimalsReceptor5-HT receptorPharmacologyCisplatinDose-Response Relationship DrugImidazolesGeneral MedicineHydroxyindoleacetic AcidReceptor antagonistOndansetronAcetylcholineSmall intestinePerfusionEndocrinologymedicine.anatomical_structurechemistryReceptors SerotoninFemaleHexamethoniumCisplatinAcetylcholinemedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Regulation of noradrenergic coerulean neuronal firing mediated by 5-HT2 receptors: involvement of the prepositus hypoglossal nucleus.

1991

Abstract Previous studies have indicated a 5-HT2-mediated inhibitory influence on unit activity in the locus coeruleus. In the present work, attempts were made to determine which area(s) of the brain is (are) involved in this effect: (1) Microiontophoretic application of serotoninergic compounds (quipazine, ketanserin, RU 24969 (Roussel Uclaf), 8-hydroxy-2(di-n-propylamino) tetralin (8-OH-DPAT), metergoline, serotonin) in the locus coeruleus, did not alter the coerulean discharge. Local microinjection of quipazine or ketanserin in the area of the locus coeruleus, as well as in one of its major afferents, the prepositus hypoglossi, had no effect on the unit activity in the locus coeruleus. 1…

Maleendocrine systemMetergolinemedicine.medical_specialtyHypoglossal NerveSerotoninKetanserinHypoglossal nucleusMicroinjectionsSerotonergicLigandsCellular and Molecular Neurosciencechemistry.chemical_compoundNorepinephrineNorepinephrineInternal medicinemedicineAnimalsheterocyclic compoundsNeurons Afferent5-HT receptorPharmacologyNeuronsChemistrymusculoskeletal neural and ocular physiologyQuipazineRats Inbred StrainsIontophoresisRatsEndocrinologynervous systemReceptors SerotoninLocus coeruleusRaphe NucleiLocus CoeruleusNeurosciencemedicine.drugNeuropharmacology
researchProduct

Chronic Fluoxetine Treatment Increases the Expression of PSA-NCAM in the Medial Prefrontal Cortex

2006

Recent hypotheses suggest that changes in neuronal structure and connectivity may underlie the etiology of depression. The medial prefrontal cortex (mPFC) is affected by depression and shows neuronal remodeling during adulthood. This plasticity may be mediated by the polysialylated form of the neural cell adhesion molecule (PSA-NCAM), which is intensely expressed in the adult mPFC. As the expression of PSA-NCAM is increased by serotonin in other cerebral regions, antidepressants acting on serotonin reuptake may influence PSA-NCAM expression and thus counteract the effects of depression by modulating neuronal structural plasticity. Using immunohistochemistry, we have studied the relationship…

Malemedicine.medical_specialtyInterneuronFluorescent Antibody TechniquePrefrontal CortexCell CountNeural Cell Adhesion Molecule L1urologic and male genital diseasesSerotonergicRats Sprague-Dawleychemistry.chemical_compoundFluoxetineInternal medicinemedicineNeuropilAnimalsPrefrontal cortexNeurotransmitter5-HT receptorNeuronsPharmacologyAnalysis of VarianceRatsPsychiatry and Mental healthmedicine.anatomical_structureEndocrinologyGene Expression Regulationnervous systemchemistryReceptors SerotoninSialic AcidsAntidepressive Agents Second-GenerationNeural cell adhesion moleculeSerotoninPsychologyNeuroscienceNeuropsychopharmacology
researchProduct

The effects of LSD in the guinea-pig ileum

1985

The effects of lysergic acid diethylamide (LSD) on acetylcholine release and on smooth muscle tone were studied in the myenteric plexus-longitudinal muscle preparation of the guinea pig. LSD (0.01-10 microM) depressed in a concentration-dependent manner the electrically-evoked [3H]-acetylcholine outflow from strips preincubated with [3H]-choline. The maximal effect was a 45% inhibition by 1 microM LSD. The spontaneous outflow was not affected. Metitepine competitively antagonized (pA2 8.0) the LSD-induced reduction of the evoked outflow. Tolazoline and mepyramine did not affect the inhibitory action of LSD. The contractions in response to electrical stimulation were enhanced by 34% in the p…

Malemedicine.medical_specialtyKetanserinGuinea PigsMepyramineMyenteric PlexusStimulationchemistry.chemical_compoundMuscle toneHistamine receptorIleumInternal medicinemedicineAnimalsReceptors Histamine H15-HT receptorPharmacologyMuscle SmoothGeneral MedicineAcetylcholineLysergic Acid DiethylamideEndocrinologymedicine.anatomical_structurechemistryMuscle TonusReceptors SerotoninMetitepineFemaleAcetylcholineMuscle Contractionmedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Potential involvement of serotonin receptor genes with age of onset and gender in schizophrenia: a preliminary study in a Spanish sample.

2009

Malemedicine.medical_specialtySample (statistics)BioinformaticsPolymorphism Single NucleotidePolymorphism (computer science)MedicineHumansAge of OnsetPsychiatryReceptorGeneBiological Psychiatry5-HT receptorSex Characteristicsbusiness.industrymedicine.diseasePsychiatry and Mental healthSchizophreniaSpainReceptors SerotoninSchizophreniaFemaleAge of onsetbusinessSex characteristicsPsychiatry research
researchProduct

Evidence for the existence of FGFR1-5-HT1A heteroreceptor complexes in the midbrain raphe 5-HT system.

2015

The ascending midbrain 5-HT neurons known to contain 5-HT1A autoreceptors may be dysregulated in depression due to a reduced trophic support. With in situ proximity ligation assay (PLA) and supported by co-location of the FGFR1 and 5-HT1A immunoreactivities in midbrain raphe 5-HT cells, evidence for the existence of FGFR1–5-HT1A heteroreceptor complexes were obtained in the dorsal and median raphe nuclei of the Sprague–Dawley rat. Their existence in the rat medullary raphe RN33B cell cultures was also established. After combined FGF-2 and 8-OH-DPAT treatment, a marked and significant increase in PLA positive clusters was found in the RN33B cells. Similar results were reached upon coactivati…

Malemedicine.medical_specialtySerotoninG-protein-coupled receptorReceptor tyrosine kinaseBiophysicsHeteroreceptor complexProximity ligation assayBiologyHeteroreceptorBiochemistryMidbrainRats Sprague-DawleyG-protein-coupled receptors; Receptor tyrosine kinases; Fibroblast growth factor receptor 1; Serotonin receptors; Heteroreceptor complex; DimerizationInternal medicinemedicineFluorescence Resonance Energy TransferAnimalsHumansReceptor Fibroblast Growth Factor Type 1Serotonin receptorMolecular Biology5-HT receptorNeurons8-Hydroxy-2-(di-n-propylamino)tetralinRapheMidbrain Raphe NucleiCell BiologyFibroblast growth factor receptor 1Cell biologyRatsmedicine.anatomical_structureEndocrinologyHEK293 Cellsnervous systemGene Expression RegulationReceptor Serotonin 5-HT1AAutoreceptorFibroblast Growth Factor 2NeuronRaphe nucleiPeptidesDimerizationProtein BindingBiochemical and biophysical research communications
researchProduct

Pravastatin treatment causes a shift in the balance of hippocampal neurotransmitter binding densities towards inhibition

2009

Since pravastatin, a HMG-CoA reductase inhibitor, has recently been shown to reduce infarct volumes and glutamate release in a rat model of ischemic stroke, the aim of the present study was to investigate whether this neuroprotective effect may be due to a modulation of excitatory and inhibitory neurotransmitter receptors. Therefore, Wistar rats were treated six times in 4 days with pravastatin or saline and allowed to survive for 6 hours or 5 days (n=10 per time point and group), respectively. Using quantitative receptor autoradiography, ligand binding densities of [(3)H]MK-801, [(3)H]AMPA, and [(3)H]muscimol for labeling of NMDA, AMPA, and GABA(A) receptors were analyzed in sensorimotor c…

Malemedicine.medical_specialtyTime FactorsKainate receptorAMPA receptorBiologyPharmacologyHippocampusReceptors N-Methyl-D-AspartateNeurotransmitter bindingRandom Allocationchemistry.chemical_compoundInternal medicinemedicineAnimalsReceptors AMPARats WistarLong-term depressionMolecular Biology5-HT receptorPravastatinCerebral CortexNeurotransmitter AgentsGABAA receptorGeneral NeuroscienceGlutamate receptorReceptors GABA-ACorpus StriatumRatsNeuroprotective AgentsEndocrinologynervous systemMuscimolchemistryNeurology (clinical)Developmental BiologyBrain Research
researchProduct

Effect of sertraline treatment on benzodiazepine receptors in the rat brain.

1993

In this paper we describe the modification of benzodiazepine (BDZ) binding sites in the rat brain after different times of treatment with the 5-hydroxytryptamine-(5HT) uptake blocker sertraline. We investigated the effect of 8, 15 and 30 days sertraline treatment (10 mg/kg/day, i.p.) on 3 H-flunitrazepam binding sites. In order to describe the anatomical site of action of the drug, the experiment has been carried out by means of quantitative receptor autoradiography. After 8 days of sertraline treatment, an increase of BDZ receptor density is found in the olfactory tubercle. This effect is reversed at 15 and 30 days. At 15 days of treatment, an increase is found in the anterior cingulate co…

Malemedicine.medical_specialtymedicine.drug_classRats Sprague-DawleyInternal medicineSertralinemedicineLimbic SystemAnimalsReceptorBiological Psychiatry5-HT receptorBrain ChemistryCerebral CortexBenzodiazepineSertralineBehavior AnimalGABAA receptorChemistryOlfactory tubercleBody WeightSeptal nucleiOlfactory PathwaysReceptors GABA-AAntidepressive AgentsRatsPsychiatry and Mental healthmedicine.anatomical_structureEndocrinology1-NaphthylamineNeurologyAnti-Anxiety AgentsCerebral cortexNeurology (clinical)Selective Serotonin Reuptake Inhibitorsmedicine.drugJournal of neural transmission. General section
researchProduct

Subtype selective binding properties of substituted linear melanocyte stimulating hormone analogues

2002

The melanocortin receptors are peptide binding G-protein coupled receptors that play a role in important physiological functions such as energy balance, inflammatory processes and several aspects of reproduction. In this study, we synthesised 11 new linear MSH analogues and tested their binding to the human MC receptors (MC1, MC3, MC4 and MC5) expressed in COS cells. Our results show that introduction of Asp in position 4 similarly affects the binding to the MC1, MC4 and MC5 receptors, but drastically lowers the binding to the MC3 receptor. Arg(5) substitution shows relatively high affinity for the MC4 receptor, while the results also give further support for specific importance of His(6) f…

Melanocyte-stimulating hormonePeptide bindingTransfectionBinding CompetitiveCell LineCellular and Molecular NeuroscienceEndocrinologyMelanocortin receptorHumans5-HT5A receptorMelanocyte-Stimulating HormonesReceptorCOS cellsEndocrine and Autonomic SystemsChemistryReceptors MelanocortinGeneral MedicineTransfectionAmino Acid SubstitutionReceptors CorticotropinNeurologyBiochemistryReceptor Melanocortin Type 4MelanocortinReceptor Melanocortin Type 1Receptor Melanocortin Type 3Neuropeptides
researchProduct

Role of serotonin in central dopamine dysfunction

2010

The interaction between serotonin (5-HT) and dopamine (DA)-containing neurons in the brain is a research topic that has raised the interest of many scientists working in the field of neuroscience since the first demonstration of the presence of monoamine-containing neurons in the mid 1960. The bulk of neuroanatomical data available clearly indicate that DA-containing neurons in the brain receive a prominent innervation from serotonin (5-hydroxytryptamine, 5-HT) originating in the raphe nuclei of the brainstem. Compelling electrophysiological and neurochemical data show that 5-HT can exert complex effects on the activity of midbrain DA neurons mediated by its various receptor subtypes. The m…

Mesocorticolimbic DA systemNigrostriatal DA systemReceptor Serotonin 5-HTParkinson's diseaseBrain microdialysisAntidepressantDopaminergic functionAntidepressantsSettore BIO/09 - Fisiologia5-HT receptorAntipsychoticParkinson diseaseMicrodialysinervous systemSingle cell recordingDrug addictionAntidepressants;Antipsychotics;Dopaminergic function;Drug addiction;5-HT receptors;Mesocorticolimbic DA system;Microdialysis;Nigrostriatal DA system;Parkinson disease;Single cell recordingAntipsychotic drugs
researchProduct